SCHEMBL8795690

SCHEMBL8795690

CC(C)(C)[Si](C)(C)OC/C(=C\c1ccccc1)c1cccc(Br)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.36
MAPT P10636 3/20 0.36
PTGS2 P35354 2/20 0.36
TP53BP1 Q12888 1/20 0.35
CCR6 P51684 1/20 0.35
PTGS1 P23219 1/20 0.34
MEN1 O00255 3/20 0.34
MTNR1A P48039 2/20 0.34
MTNR1B P49286 2/20 0.34
CYP19A1 P11511 2/20 0.34
CYP1A2 P05177 2/20 0.34
KDM4E B2RXH2 1/20 0.34
MAPK1 P28482 1/20 0.34
NPC1 O15118 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
CASP3 P42574 1/20 0.34
HTT P42858 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
CYP1A1 P04798 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8795697 1.00 KMT2A (0.36) KMT2AMAPTPTGS2TP53BP1CCR6
SCHEMBL8795848 0.83 PLA2G4A (0.46) MAPTNPC1SMN1; SMN2NFKB1NFKB2
SCHEMBL8795838 0.83 PLA2G4A (0.46) MAPTNPC1SMN1; SMN2NFKB1NFKB2
SCHEMBL8795499 0.83 KMT2A (0.44) KMT2AMAPTMEN1CYP1A2KDM4E
SCHEMBL8795222 0.83 KMT2A (0.44) KMT2AMAPTMEN1CYP1A2KDM4E
SCHEMBL8796136 0.81 NPC1 (0.39) MAPTTP53BP1KDM4ENPC1SMN1; SMN2
SCHEMBL8796142 0.81 NPC1 (0.39) MAPTTP53BP1KDM4ENPC1SMN1; SMN2
SCHEMBL8796491 0.81 RARG (0.38) CYP1A2KDM4ENPC1CYP2C19CYP3A4
SCHEMBL8796493 0.81 RARG (0.38) CYP1A2KDM4ENPC1CYP2C19CYP3A4
SCHEMBL8796294 0.80 PTPN11 (0.36) KMT2AMEN1SMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0629604-B1 Alicyclic phospholipase A2 inhibitors BRISTOL MYERS SQUIBB CO (US) 1997-04-16 EP disclosed
US-5436369-A Alicyclic phospholipase A2 inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 1995-07-25 US disclosed
EP-0629604-A2 Alicyclic phospholipase A2 inhibitors Bristol-Myers Company (US) 1994-12-21 EP disclosed